The use of MS-MLPA is essential for the diagnosis of 6q24-TNDM, identifying paternal UPD6, paternal 6q24 duplications, or isolated maternal hypomethylation of the PLAGL1/HYMAI locus in patients with diabetes diagnosed in the first weeks of life and other coexisting disorders. Here, PLAGL1 is linked to diabetes mellitus.